Melanie Hermann
Evotec SE, Germany
Biography
Melanie Hermann has completed her PhD at the German Cancer Research Center in Heidelberg, Germany by working on a Transgenic Mouse Model for Skin Cancer. Afterwards she was working as a Postdoc in the Department of Neurosurgery at UCSF, San Francisco, USA, where she did her studies on stroke and traumatic-brain-injury mouse models. Back in Germany, she continued her studies in the Department of Neuropathology at UKE, Hamburg,
Germany by working in the field of Prion disease and the rare Neurodegenerative disease FENIB (familial encephalopathy with neuroserpin inclusion bodies). Afterwards, she has started her carrier in industry and is now working as a Senior Research Scientist on different drug discovery programs at Evotec SE Hamburg by taking the Lead of high content histology approaches for target validation.
Abstract
Abstract : High content histology in drug discovery programs – A tool for target validation